AnalystsMadison El-SaadiMadison El-Saadi's Stock Forecasts
AnalystsMadison El-Saadi
Sectors:
Analyst Ranking
Top 32%
#1659 out of 5153 analysts
Average Return
+18.26%
Win Rate
55%6 out of 11
Risk vs Reward
Poor
Good
Madison El-Saadi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Capricor Therapeutics IncCAPR | +160.81% | $10.18 | $26.55 | 2025-06-25 - 2025-12-15 | Strong Buy |
Vanda Pharmaceuticals IncVNDA | +49.32% | $4.44 | $6.63 | 2025-11-04 - 2025-12-15 | Strong Buy |
Axsome Therapeutics IncAXSM | +23.34% | $118.57 | $146.24 | 2025-09-30 - 2025-12-15 | Strong Buy |
Eton Pharmaceuticals IncETON | +18.68% | $13.44 | $15.95 | 2025-01-09 - 2025-12-15 | Strong Buy |
Wave Life Sciences LtdWVE | +17.17% | $5.94 | $6.96 | 2024-09-18 - 2025-09-18 | Strong Buy |
Madison El-Saadi Analyst Color
Get additional color on Madison El-Saadi's coverage of popular stocks
Madison El-Saadi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Capricor Therapeutics IncCAPR | 2 | Strong Buy | $50.00 | +88.32% | Reiterates | a day ago |
Wave Life Sciences LtdWVE | 4 | Strong Buy | $37.00 | +129.67% | Maintains | 4 days ago |
Vanda Pharmaceuticals IncVNDA | 1 | Strong Buy | $11.00 | +65.91% | Initiates Coverage On | a month ago |
Axsome Therapeutics IncAXSM | 1 | Strong Buy | $179.00 | +22.40% | Initiates Coverage On | 3 months ago |
Eton Pharmaceuticals IncETON | 3 | Strong Buy | $26.00 | +63.01% | Reiterates | 7 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.